MOEBIUS MEDICAL
Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track statusSun Pharma and Moebius Medical have received fast track designation from the USFDA for their non-opioid therapy MM-II, aimed at treating os...
Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trialsSun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 we...
Fifteen stocks in focus on Tuesday, 13 December 2016Dairy firm Kwality on Monday reported a 12 per cent increase in its net profit at Rs 42.07 crore for the second quarter of this fiscal. The...
Sun Pharma, Moebius Medical to develop osteoarthritis pain productMM-II is an intra-articular bio lubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthrit...
Load More